ESC Premium Access

Pharmacokinetic and pharmacodynamic assessment of a lipid-based aspirin formulation: results of a prospective, randomised, crossover study

Congress Session

About the speaker

Doctor Dominick Joseph Angiolillo

University of Florida College of Medicine, Jacksonville (United States of America)
23 presentations
0 follower

6 more presentations in this session

A randomized controlled trial evaluating outcome impact of cilostazol in patients with coronary artery disease and at a high risk of cardiovascular disease

Speaker: Professor T. Chao (Tainan, TW)

Thumbnail

Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study

Speaker: Professor D. Angiolillo (Jacksonville, US)

Thumbnail

Effect of de-escalated switching dual antiplatelet therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: real-world data from a nationwide cohort study

Speaker: Doctor C. Hsu (Taipei, TW)

Thumbnail

Predictors of DAPT use in patients beyond 1 year post myocardial infarction: Insights from the TIGRIS observational study

Speaker: Doctor J. Russo (Ottawa, CA)

Thumbnail

Comparing treatment recommendations for the DAPT and PRECISE-DAPT scores after percutaneous coronary intervention

Speaker: Doctor R. B (Ottawa, CA)

Thumbnail

Access the full session

Evolving developments in anti-platelet therapy

Speakers: Doctor D. Angiolillo, Professor T. Chao, Professor D. Angiolillo, Doctor C. Hsu, Doctor J. Russo...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk